Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Nature Genetics2015Vol. 48(2), pp. 183–188
Citations Over TimeTop 10% of 2015 papers
Jessica Okosun, Rachel L. Wolfson, Jun Wang, Shamzah Araf, Lucy Wilkins, Brian M. Castellano, Leire Escudero‐Ibarz, Ahad Al Seraihi, Julia Richter, Stephan Wolf, Alejo Efeyan, Sameena Iqbal, Janet Matthews, Andrew Clear, José Afonso Guerra‐Assunção, Csaba Bödör, Hilmar Quentmeier, Christopher Mansbridge, Peter Johnson, Andrew Davies, Jonathan C. Strefford, Graham Packham, Sharon Barrans, Andrew Jack, Ming‐Qing Du, Maria Calaminici, T. Andrew Lister, Rebecca Auer, Silvia Montoto, John G. Gribben, Reiner Siebert, Claude Chelala, Roberto Zoncu, David M. Sabatini, Jude Fitzgibbon
Related Papers
- → Inhibition of mTORC1 by Astrin and Stress Granules Prevents Apoptosis in Cancer Cells(2013)356 cited
- → AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation(2023)38 cited
- → Regulation of Mammalian Target of Rapamycin Complex 1 by Bcl-2 and Bcl-XL Proteins(2013)17 cited
- → Hayatine inhibits amino acid-induced mTORC1 activation as a novel mTOR-Rag A/C interaction disruptor(2021)2 cited
- → Environmental Sensing by mTORC1(2021)